JP2008517046A5 - - Google Patents

Download PDF

Info

Publication number
JP2008517046A5
JP2008517046A5 JP2007537377A JP2007537377A JP2008517046A5 JP 2008517046 A5 JP2008517046 A5 JP 2008517046A5 JP 2007537377 A JP2007537377 A JP 2007537377A JP 2007537377 A JP2007537377 A JP 2007537377A JP 2008517046 A5 JP2008517046 A5 JP 2008517046A5
Authority
JP
Japan
Prior art keywords
human
buffer
anion exchange
substrate
fraction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007537377A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008517046A (ja
JP4950053B2 (ja
Filing date
Publication date
Priority claimed from GBGB0423196.5A external-priority patent/GB0423196D0/en
Application filed filed Critical
Publication of JP2008517046A publication Critical patent/JP2008517046A/ja
Publication of JP2008517046A5 publication Critical patent/JP2008517046A5/ja
Application granted granted Critical
Publication of JP4950053B2 publication Critical patent/JP4950053B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007537377A 2004-10-19 2005-10-19 ハプトグロビンの単離方法 Expired - Lifetime JP4950053B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0423196.5 2004-10-19
GBGB0423196.5A GB0423196D0 (en) 2004-10-19 2004-10-19 Method
PCT/GB2005/004037 WO2006043062A1 (en) 2004-10-19 2005-10-19 Method for the isolation of haptoglobin

Publications (3)

Publication Number Publication Date
JP2008517046A JP2008517046A (ja) 2008-05-22
JP2008517046A5 true JP2008517046A5 (https=) 2008-11-27
JP4950053B2 JP4950053B2 (ja) 2012-06-13

Family

ID=33484812

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007537377A Expired - Lifetime JP4950053B2 (ja) 2004-10-19 2005-10-19 ハプトグロビンの単離方法

Country Status (13)

Country Link
US (1) US9145448B2 (https=)
EP (1) EP1802654B1 (https=)
JP (1) JP4950053B2 (https=)
AT (1) ATE539085T1 (https=)
AU (1) AU2005297061B2 (https=)
BR (1) BRPI0516933B8 (https=)
CA (1) CA2584407C (https=)
ES (1) ES2379157T3 (https=)
GB (1) GB0423196D0 (https=)
IL (1) IL182340A (https=)
MX (1) MX2007004244A (https=)
PL (1) PL1802654T3 (https=)
WO (1) WO2006043062A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0423196D0 (en) 2004-10-19 2004-11-24 Nat Blood Authority Method
CN112717125A (zh) * 2012-10-03 2021-04-30 瑞士杰特贝林生物制品有限公司 一种纯化蛋白质的方法
US9534029B2 (en) 2012-10-03 2017-01-03 Csl Behring Ag Method of purifying proteins
WO2020160505A1 (en) * 2019-02-01 2020-08-06 Ohio State Innovation Foundation Methods of protein purification
EP3972646A4 (en) * 2019-05-20 2023-06-14 Ohio State Innovation Foundation APOHEMOGLOBIN-HAPTOGLOBIN COMPLEXES AND METHODS OF USE THEREOF
US20240034749A1 (en) * 2021-02-04 2024-02-01 Green Cross Corporation Method for purification of hemopexin and haptoglobin
CN115531921B (zh) * 2022-08-26 2024-07-16 大连依利特分析仪器有限公司 一种制备型液相色谱馏分收集装置及方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1426039A (en) 1973-11-15 1976-02-25 Green Cross Corp Haptoglobin in aqueous solution and process for tits preparation
US4061735A (en) * 1973-11-15 1977-12-06 The Green Cross Corporation Haptoglobin in aqueous solution and process for preparing the same
JPS5337406B2 (https=) * 1973-11-15 1978-10-09
US4137307A (en) * 1973-11-15 1979-01-30 The Green Cross Corporation Process for preparing haptoglobin aqueous solution using strong anion exchanger
JPS52128205A (en) * 1976-04-16 1977-10-27 Green Cross Corp:The Prophylactic and therapeutic drugs for cerebro-vascular contraction
US4540573A (en) 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
US5094960A (en) * 1988-10-07 1992-03-10 New York Blood Center, Inc. Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography
JP3554796B2 (ja) 1988-10-31 2004-08-18 三菱ウェルファーマ株式会社 アルブミン製剤及びその製造方法
JP3825061B2 (ja) * 1994-09-28 2006-09-20 三菱ウェルファーマ株式会社 ハプトグロビンの製造方法
DE19960500A1 (de) * 1999-12-15 2001-07-12 Giesing Michael Antikörper und Verfahren zu ihrer Herstellung, deren Verwendung sowie Immunisierungscocktails, Immunoassay-Sets und Peptide
AU2002210383A1 (en) * 2000-10-16 2002-04-29 Proteopharma Aps The function of a haptoglobin-haemoglobin receptor and the uses thereof
US20030113830A1 (en) 2001-07-11 2003-06-19 Rappaport Family Institute For Research In The Medical Sciences Novel antioxidant, nucleic acid constructs encoding same, pharmaceutical compositions containing same and use of same for reducing oxidative-stress
JP2004244348A (ja) * 2003-02-13 2004-09-02 Nihon Pharmaceutical Co Ltd パプトグロビンの精製法
GB0423196D0 (en) 2004-10-19 2004-11-24 Nat Blood Authority Method
WO2006107708A1 (en) 2005-04-04 2006-10-12 Alexion Pharmaceuticals, Inc. Treatment of disease caused by excess free hemoglobin

Similar Documents

Publication Publication Date Title
JP6820232B2 (ja) アニオン交換クロマトグラフィーによるタンパク質の精製
JPS5944320A (ja) C1不活性化剤の調製方法
JP2013514073A5 (https=)
JP2013511566A5 (https=)
JP2013500711A5 (https=)
JP2005500265A (ja) 治療的使用のためのヒト免疫グロブリン濃縮物の調製方法
CN101796065A (zh) 纯化因子VIII和Von Willebrand因子的方法
JPS6098988A (ja) Lpf−haの精製法
TWI407994B (zh) 分離核酸的方法、試劑及套組
JP2008517046A5 (https=)
JPH06321994A (ja) アンチトロンビン調製物およびその調製方法
JP2007523883A5 (https=)
FR2676231A1 (fr) Concentre de facteur xi de la coagulation sanguine a haute activite specifique, approprie a usage therapeutique et son procede de preparation.
IL182340A (en) A method of isolating hepatoglobin from the V segment of human COHN
CN103060294B (zh) 一种能够去除热原及病毒的尿激酶的制备方法
CN107827974A (zh) 一种人纤维蛋白原的制备方法
JPH05279396A (ja) 第viii因子の精製法と、それによって得られた調製品
JP2014501721A (ja) FXIおよびFXIaを、これら凝固因子を含む溶液から減少させるおよび/または除去するための方法
CN102115739B (zh) 分离核酸的方法、试剂及套组
JP2006042820A5 (https=)
JPH02113893A (ja) 凝固因子2、7、9およびxの1または2以上を濃縮する方法
US11584777B2 (en) Method for purifying a sulfatase protein
JP4060123B2 (ja) タンパク質の失活を抑制する方法
JP3920913B2 (ja) タンパク質の分離方法
GB1601744A (en) Processes for the purification of interferon certain new and useful intermediates formed therein the purified interferon thus produced and pharmaceutical compositions containing